UBS analyst Matthew Weston maintained a Buy rating on AstraZeneca (AZN – Research Report) today and set a price target of p14,200.00. The company’s shares opened today at p10,226.00.

EXCLUSIVE: Blue Peter is a 67-year-old British television institution — and now the BBC is relaunching the kids series with a new format and studio home. Blue Peter is switching from a live to a ...

Tempus AI (TEM) announced multi-year, strategic collaborations with AstraZeneca (AZN) and Pathos AI, Inc., in which the companies will work together to build a multimodal foundation model in ...

On 1 May 2005, the Organization for the Advancement of Structured Information Standards (OASIS) recognized the Open Document Format (ODF) as the standard for an open source file format for office ...

After a thrilling and at times gut-wrenching final round of the 2025 Masters, 72 holes was not enough to determine a champion. Justin Rose posted 11 under in the clubhouse with a scintillating ...

When the 2028 Olympics rolls around, there will be more gold medals to be won in the sport of golf. On April 9, the International Olympic Committee announced that several new medal opportunities ...

Grab your partner and let's play some golf as the PGA Tour travels down to the Bayou this week for the 2025 Zurich Classic. Hosting the annual team event at TPC Louisiana, the Zurich Classic will ...

Visit a quote page and your recently viewed tickers will be displayed here.

PNG is a widely used format for high-quality web images with transparency support, but BMP (Bitmap) files are still preferred in certain legacy systems, engineering software, or Windows-based ...

Copyright © 2025 MarketWatch, Inc. All rights reserved.